Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Abstract Background Herein, we describe the use of systemic immunotherapy for both locally advanced and metastatic conjunctival melanoma. Current treatments for advanced conjunctival melanoma typically result in poor local control leading to disfiguring orbital exenteration surgery. Locoregional spr...
Main Authors: | Paul T. Finger, Anna C. Pavlick |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-03-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0555-7 |
Similar Items
-
Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan
by: Chiao-En Wu, et al.
Published: (2020-06-01) -
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
by: Karlsson AK, et al.
Published: (2017-08-01) -
Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy
by: Michael Chang, et al.
Published: (2019-01-01) -
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
by: Marieke J. Krimphove, et al.
Published: (2019-11-01) -
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
by: Ernesto Rossi, et al.
Published: (2019-07-01)